139 related articles for article (PubMed ID: 25940796)
1. Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion.
Prithviraj P; Anaka M; McKeown SJ; Permezel M; Walkiewicz M; Cebon J; Behren A; Jayachandran A
Oncotarget; 2015 Jun; 6(18):15953-65. PubMed ID: 25940796
[TBL] [Abstract][Full Text] [Related]
2. Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target.
Huang J; Tabata S; Kakiuchi S; The Van T; Goto H; Hanibuchi M; Nishioka Y
Oncotarget; 2013 Aug; 4(8):1172-84. PubMed ID: 23896451
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression.
Zhang J; Zhang Y; Li L; Nian Y; Chen Y; Shen R; Ma X
Bioengineered; 2022 Jan; 13(1):291-307. PubMed ID: 34974815
[TBL] [Abstract][Full Text] [Related]
4. Identifying and targeting determinants of melanoma cellular invasion.
Jayachandran A; Prithviraj P; Lo PH; Walkiewicz M; Anaka M; Woods BL; Tan B; Behren A; Cebon J; McKeown SJ
Oncotarget; 2016 Jul; 7(27):41186-41202. PubMed ID: 27172792
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series.
Marzocchi C; Capezzone M; Sagnella A; Cartocci A; Caroli Costantini M; Brindisi L; Mancini V; Cantara S; Castagna MG
J Endocrinol Invest; 2022 Feb; 45(2):369-378. PubMed ID: 34350538
[TBL] [Abstract][Full Text] [Related]
6. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy-associated plasma protein A regulates mitosis and is epigenetically silenced in breast cancer.
Loddo M; Andryszkiewicz J; Rodriguez-Acebes S; Stoeber K; Jones A; Dafou D; Apostolidou S; Wollenschlaeger A; Widschwendter M; Sainsbury R; Tudzarova S; Williams GH
J Pathol; 2014 Aug; 233(4):344-56. PubMed ID: 24931331
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development.
Conover CA; Bale LK; Overgaard MT; Johnstone EW; Laursen UH; Füchtbauer EM; Oxvig C; van Deursen J
Development; 2004 Mar; 131(5):1187-94. PubMed ID: 14973274
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma.
Jayachandran A; Anaka M; Prithviraj P; Hudson C; McKeown SJ; Lo PH; Vella LJ; Goding CR; Cebon J; Behren A
Oncotarget; 2014 Jul; 5(14):5782-97. PubMed ID: 25051363
[TBL] [Abstract][Full Text] [Related]
10. Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.
Pan H; Hanada S; Zhao J; Mao L; Ma MZ
PLoS One; 2012; 7(11):e48799. PubMed ID: 23152806
[TBL] [Abstract][Full Text] [Related]
11. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
[TBL] [Abstract][Full Text] [Related]
12. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
[TBL] [Abstract][Full Text] [Related]
14. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
16. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
18. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
19. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
